【レポートの概要（一部）】
1. Report Overview
1.1 Pharma Contract Sales Overview
1.2 Why You Should Read This Report
1.3 How this Report Delivers
1.4 Main Questions Answered by this Report
1.5 Who is this Report for?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQ)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to and Definition of the Pharma Contract Sales Market
2.1 Defining the Market
2.2 What is a CSO?
2.3 What Services do CSOs Provide?
2.4 The Different Marketing Channels Employed by Pharma Companies in 2016
2.5 Growing Trend of Outsourcing in the Overall Pharma Industry
2.6 The Rise in Pharma Contract Sales
2.7 Detailing: Becoming Less Relevant or is it as Important as Ever?
2.7.1 Declining Access to Doctors: Trend Continues in 2016
2.8 Large Cuts in Sales Force in Various Companies
2.9 Companies Cannot Rely Solely Upon Detailing
2.9.1 Trends Driving the Need for New Sales Models
3. Global Pharma Contract Sales Market 2016-2026
3.1 The Market in 2015
3.2 Global Pharma Contract Sales Market 2010-2015
3.2.1 Decent Growth in Past Six Years
3.3 Global Pharma Contract Sales Market 2016-2026
3.4 The Factors that will Drive Growth in this Market: Advantages of Outsourcing Pharma Sales
3.4.1 Cost and Flexibility
3.4.2 New Technologies and Sales Models
3.4.3 Emerging Markets and Mature Brands
3.4.4 Biosimilars
3.4.5 Account Management, Medical Education and Patient Support Services
3.4.6 Market Access Complexities Provide its Own Opportunities for CSOs
3.4.7 New Drug Launches
3.4.8 Summary
3.5 The Factors that will Restrain Growth in this Market: Disadvantages of Outsourcing Pharma Sales
3.6 Leading Therapeutic Submarkets for Pharma Contract Sales, Forecast 2016-2026
3.7 How Will the Therapeutic Composition of the Market Change Between now and 2026?
3.8 Contract Sales for Cardiovascular Drugs
3.8.1 Current Status
3.8.2 Recent Cardiovascular Drug Patent Expiries and FDA Approvals
3.8.3 Cardiovascular and Cerebrovascular Conditions are the World’s Most Fatal Diseases
3.8.4 Contract Sales for Cardiovascular Drugs: Submarket Forecast 2016-2026
3.9 Contract Sales for Metabolic Disorder Drugs
3.9.1 Current Status
3.9.2 430 Million People Expected to be Diagnosed with Diabetes by 2030
3.9.3 Contract Sales for Metabolic Disorders: Submarket Forecast 2016-2026
3.10 Contract Sales for Oncology Drugs
3.10.1 Current Status
3.10.2 Patent Expiries and Recent Approvals
3.10.3 Contract Sales for Oncology Drugs Forecast 2016-2026
4. Leading Service Sectors of the Pharma Contract Sales Market 2016-2026
4.1 The Leading Services
4.1.1 Leading Service Sectors of the Market, Forecast 2016-2026
4.1.2 How Will the Service Composition over the Market Change over the Next Ten Years?
4.2 Contract Detailing Submarket
4.2.1 Are we in the Midst of a Turnaround in Sales Rep Numbers in the Overall Pharma Industry?
4.2.2 What are the Trends in Sales Reps Employed by CSOs?
4.2.3 Detailing Services Offered by CSOs
4.2.4 CSOs will be Impacted by Declining Physician Access as Much as In-House Reps
4.2.5 Contract Detailing Submarket Forecast 2016-2026
4.2.6 Drivers and Restraints for this Dominant Service Submarket
4.3 Contract Non-Personal Promotion
4.3.1 The Benefits for both Pharma Companies and Doctors
4.3.2 Contract Non-Personal Promotion Submarket Forecast 2016-2026
4.3.3 Drivers and Restraints for Contract Non-Personal Promotion: Multichannel Marketing in the 21st Century
4.3.4 Further Sub-Sectors Within the Contract Non-Personal Promotion Submarket: Teledetailing and EDetailing
4.3.4.1 Contract Teledetailing Submarket: Current Status
4.3.4.2 Contract Teledetailing Submarket Forecast 2016-2026
4.3.4.3 Drivers and Restraints for Outsourced Teledetailing
4.3.4.4 Contract eDetailing Current Status
4.3.4.5 Contract eDetailing Submarket Forecast 2016-2026
4.3.4.6 Drivers and Restraints for Outsourced eDetailing
4.4 Medical Education Services Submarket Current Status
4.4.1 Medical Education Services Submarket Forecast 2016-2026
4.4.2 Medical Education Services Drivers and Restraints
4.5 Sample Management Services Submarket: Current Status
4.5.1 Sample Management Services Submarket Forecast 2016-2026
4.5.2 Drivers and Restraints for the Sample Management Services Submarket
4.5.3 J. Knipper and Company Inc: A US Leader in Sample Management Services
4.5.3.1 Company Acquires Sample Management Divisions from Leading CSOs 2010-2014
4.5.3.2 Construction Underway for New State of the Art Distribution Centre
4.5.3.3 New Multi-Million Dollar Contact Centre Opened
4.5.3.4 New Technologies to Drive Growth Over Next Ten Years
5. Leading National Markets for Pharma Contract Sales: Regulatory and Commercial Outlook 2016-2026
5.1 Current Leading National Markets
5.2 Leading Regional Markets Forecast 2016-2026
5.3 How will the Regional Composition of the Market Change between now and 2026?
5.4 Pharma Sales Regulatory Developments
5.4.1 Physician Payment Legislation in the US, Europe and Japan
5.4.1.1 The Physician Payment Sunshine Act (PPSA)
5.4.1.2 Proposed Bill to Close a Large Loophole in the PPSA, Could Come into Effect in 2017
5.4.1.3 Physician Payments in France: Increased Scrutiny
5.4.2 Domestic and International Concerns over Bribery: Recent Legislation in the US and UK
5.4.2.1 Promotional Products in the EU: New Rules
5.4.3 New Market Access Requirements in EU5 Countries
5.4.3.1 AMNOG: Stricter Pricing for Drugs in Germany
5.4.3.2 AMNOG: Has Reduced Prices of Top Sellers by 23%
5.4.3.3 Healthcare Reform in France: Pricing and Reimbursements have been set to Change for a While, is 2016 the Year it Finally Happens?
5.4.3.4 PCTs Replaced by CCGs in the UK
5.4.3.5 Pricing in the UK: Contentious Issue
5.4.4 Overtime for Sales Reps in the US: Rule Clarifications
5.5 US Pharma Contract Sales Market
5.5.1 Has Come a Long Way
5.5.2 Pharma Sales Regulation in the US
5.5.3 Trends in 2015 as Witnessed by a Large CSO
5.5.4 US Pharma Contract Sales Market Forecast 2016-2026
5.6 EU5 Pharma Contract Sales Market
5.6.1 Regulating Pharma Sales in the EU
5.6.2 Overall EU5 Pharma Contract Sales Market Forecast 2016-2026
5.6.3 UK Pharma Contract Sales Market Forecast 2016-2026
5.6.4 German Pharma Contract Sales Market Forecast 2016-2026
5.6.5 French Pharma Contract Sales Market Forecast 2016-2026
5.6.6 Italian Pharma Contract Sales Market Forecast 2016-2026
5.6.7 Spanish Pharma Contract Sales Market Forecast 2016-2026
5.7 Japanese Pharma Contract Sales Market
5.7.1 Regulation
5.7.2 Trends in 2015 as Witnessed by a Large CSO
5.7.3 Current Market Landscape
5.7.4 Japanese Pharma Contract Sales Market Forecast 2016-2026
6. Leading Emerging Markets for Pharma Contract Sales: Regulatory and Commercial Outlook 2016-2026
6.1 Pharma Contract Sales in Leading Emerging Markets in 2015
6.2 BRIC Pharma Contract Sales Markets Forecast 2016-2026
6.3 Chinese Pharma Contract Sales Market
6.3.1 Current Pharma Contract Sales Landscape in China
6.3.2 Rising In-House and Outsourced Sales Numbers
6.3.3 Concerns over Bribery
6.3.4 Chinese Pharma Contract Sales Market Forecast 2016-2026
6.4 Indian Pharma Contract Sales Market
6.4.1 Current Pharma Contract Landscape in India
6.4.2 Government and Regulatory Guidelines for Interactions Between Healthcare Professionals and Pharma Companies
6.4.3 Indian Pharma Contract Sales Market Forecast 2016-2026
6.5 Brazilian Pharma Contract Sales Market
6.5.1 Current Pharma Contract Sales Landscape in Brazil
6.5.2 State Payment Rules and Online Marketing Rules for Prescription Drugs
6.5.3 Brazilian Pharma Contract Sales Market Forecast 2016-2026
6.6 Russian Pharma Contract Sales Market
6.6.1 Current Pharma Contract Sales Landscape in Russia
6.6.2 New State Procurement Rules for Drugs Introduced in 2013
6.6.3 Tougher Rules on Interactions Between Doctors and Sales Reps in Russia
6.6.4 Russian Pharma Contract Sales Market Forecast 2016-2026
7. Pharma Contract Sales: Industry and Market Trends 2016-2026
7.1 Strengths and Weaknesses for the Global Pharma Contract Sales Market 2016-2026
7.2 Opportunities and Threats for the Global Pharma Contract Sales Market 2016-2026
7.3 Pharma Contract Sales Market: STEP Analysis 2016-2026
7.3.1 Social Factors Affecting Pharma Contract Sales to 2026
7.3.1.1 The Role of Ethics in Pharma Sales
7.4 Technological Developments to Improve Sales Strategies
7.4.1 Advantages of Using Tablets and Smartphones for Detailing
7.4.1.1 CSOs Need to Maximise on the Benefits of New Technologies
7.4.2 Closed Loop Marketing (CLM)
7.4.3 Customer Relationship Management (CRM)
7.4.4 The Advantages of Cloud Computing in Pharma Contract Sales
7.4.5 Does Big Data Have a Role in Pharma Sales?
7.4.6 Social Media in Relation to Pharma Sales
7.4.6.1 FDA Releases Long-Awaited Guidance on the use of Social Media
7.4.6.2 Pharma Industry is not Using Social Media to its Full Potential, but it Offers many Benefits
7.5 Economic Pressures are Limiting Healthcare and Marketing Budgets
7.6 Political Issues: Stricter Regulations for Pharma Sales around the World
7.7 Trends in Pharma Contract Sales 2016-2026
7.7.1 Cuts to In-House Sales Staff will Continue 2016-2026
7.7.2 There will be in an Increase in Strategic Partnering in Order to Provide Long-Term Revenue Growth
7.7.3 Leading CSOs have Consolidated, and will Continue to Consolidate, in Order to Increase Market Penetration
7.7.4 CSOs and Pharma Clients Alike Need to Stay Vigilant about the Risks of Outsourcing Pharma Sales
7.8 Drug Development Trends Affecting Pharma Sales 2016-2026
7.8.1 How will Orphan Drug Diseases Influence Pharma Contract Sales?
7.8.2 Promotion for Biosimilar Drugs over the Next Ten Years
7.8.3 There will be Greater Demand for Specialty Medicines
7.8.4 Emerging National Markets are Becoming Increasingly Important
7.9 Sales Models Need to Evolve with the Times
7.9.1 Why are Sales Reps Struggling for Access?
7.9.1.1 One way to Fight Against Reduced Access is to Target the System as a Whole
7.9.1.2 Multichannel Marketing to Overcome Problems of Access
7.9.2 Key Account Management (KAM)
7.9.3 Silos in Sales and Marketing
7.9.4 The Use of KOLs in Pharma Sales
7.10 Market Access
7.10.1 Emerging Stakeholders in Pharma Sales
7.10.2 The Rise of ACOs
7.10.2.1 20% of US Hospitals were Part of an ACO in 2014
7.10.3 Market Access in the EU Over the Next Ten Years
7.10.4 CSOs and Market Access Consulting
7.11 Summary: Main Trends Shaping Pharma Contract Sales 2016-2026
8. Leading Contract Sales Organisations (CSOs)
8.1 Current Industry Landscape
8.2 Quintiles
8.2.1 World Market Leader for Contract Sales and Market Access
8.2.2 New Services and Strategic Partnerships
8.2.3 Quintiles Integrated Health Services Segment Performance 2010-2015
8.2.4 Outlook for Quintiles Contract Sales to 2026
8.3 UDG Healthcare
8.3.1 Global Service Provider with Various Business Units
8.3.2 Geographic and Service Growth Through Acquisitions
8.3.3 Joint Venture with CMIC
8.3.4 UDG Healthcare Financial Performance 2010-2015 and Beyond
8.4 inVentiv Health
8.4.1 Combined CRO and CCO
8.4.2 Global Structure
8.4.3 inVentiv Health Presence in US, EU and Asia
8.4.4 Possible $500m IPO in the Near Future
8.4.5 inVentiv Health Contract Sales Outlook to 2026
8.5 Publicis Healthcare Communications Group
8.5.1 PHCG Purchases PDI Commercial Services Business
8.5.1.1 PDI Prior to Acquisition: Broad Service Portfolio, Resources which PHCG now Acquires
8.5.1.2 PDI Past Financial Performance
8.5.2 Publicis Touchpoint Solutions
8.5.2.1 New Services in Recent Years, and Tardis Medical to be Aligned with the Company
8.6 OnCall, LLC
8.6.1 Range of Services
8.6.2 Contracts with Promius Pharma
8.7 Marvecs
8.7.1 A Local Leader in Germany
8.7.2 New Services Added in Recent Years: Sales 3.0
8.8 Sofip: Contract Sales for the French Submarket
8.9 CMIC
8.9.1 CSO Business in Japan Since 2000
8.10 Leading Players in China are not Just CSOs
9. Research Interviews
9.1 Walter R. Dewees, Executive Vice-President, OnCall LLC
9.1.1 OnCall, LLC
9.1.2 Promotional Outsourcing in the US
9.1.3 Increasing Engagement via Technology-Enabled Multi-Channels
9.1.4 Growing Medical Science Liaison Function
9.1.5 Risk-Sharing Agreement
9.2 Tony Swift, Managing Director, Apodi
9.2.1 Apodi
9.2.2 Market Access Challenges in the UK
9.2.3 CSOs Can Promote Partnership Between Pharma and the NHS
9.2.4 Value Propositions Offered by CSOs
9.3 Holger C.W. Fürstenberg, Founder and Managing Director, Hilver
9.3.1 Hilver
9.3.2 Integrating CLM and Digital Strategy Remains a Challenge
9.3.3 CLM Implementation – Bridging Sales and Marketing
9.3.4 Company Culture is yet to Fully Embrace Digital Toolsets
9.3.5 Digital Tools Facilitate Unparalleled Customer Service
10. Conclusions of the Research and Analysis
10.1 The Global Pharma Contract Sales Market in 2015
10.1.1 Which Sectors Generated the Most Revenues in 2015?
10.1.2 Spending on Contract Sales is Highest in the US and EU
10.2 Outlook for the Pharma Contract Sales Market 2016-2026
10.2.1 Growth Trends for the Leading Submarkets 2016-2026
10.2.1.1 Therapeutic Sector Growth 2016-2026
10.3 Commercial Drivers for Pharma Contract Sales
【レポート販売概要】
■ タイトル：医薬品契約販売の世界市場2016-2026■ 英文：Pharma Contract Sales Market 2016-2026 : Revenue Forecasts for Outsourced Detailing, Including Teledetailing and eDetailing, as well as Medical Education and Sample Management Services
■ 発行日：2016年3月
■ 調査会社：visiongain
■ 商品コード：VGAIN6041537
■ 調査対象地域：グローバル
- 産業用真空ポンプの世界市場2016-2020About the Industrial Vacuum Pump Market Vacuum pumps are used to remove gas molecules from a sealed space or enclosure or a package. Despite the emergence of solid state electronics, vacuum pumping technology has evolved and its application has grown significantly. This technology plays a central role in at least 70 general manufacturing uses such as compression and drying that cover a wide range …
- 分路リアクトルの世界市場：油浸型分路リアクトル、空心型分路リアクトルAbout Shunt Reactor A shunt reactor is used to protect a transmission line from high voltage levels. The reactance of a transmission line consumes reactive power along the line when it is loaded. Reactance is the characteristic of electrical or electronic equipment to oppose changes in electric current or voltage because of inductance or capacitance. Technavio's analysts forecast the global shunt …
- パルスオキシメーターの世界市場：指先型、携帯型、手首型、卓上型パルスオキシメーターAbout Pulse Oximetry Pulse oximetry is a non-invasive method used to measure the arterial oxygen saturation level in a patient's blood. Pulse oximetry works on the principle of spectrophotometry. The technique makes use of characteristics of hemoglobin for absorption of light and the pulsating nature of blood flow in the arteries. Using a pulse oximeter, hypoxia (a condition in which there is an i …
- 消費者直結型遺伝子検査の世界市場2015-2019About Genetic Testing Genetic testing is the most profitable and rapidly expanding segment of molecular diagnostics. It is the array of techniques used for the analysis of DNA, RNA, and protein. It is used as a medical tool to determine the genetic defects associated with a particular disease. Genetic testing is also used in non-clinical applications such as paternity testing and forensics. In cli …
- 世界のパルスオキシメーター市場2015The Global Pulse Oximeters Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Pulse Oximeters industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Pulse Oximeters market analysis is provided for the international markets including development trends, co …
- 世界のビルオートメーション及び制御市場The report, based on the extensive research study of the global building automation and controls market, is aimed at identifying the entire market of the building automation and controls specifically lighting, security & access, HVAC, entertainment, outdoor controls, elevator controls and BMS. The report covers the overall market and sub-segment markets through extensively detailed classifications …
- 世界の個人衛生製品市場動向：企業M&A（2014年5月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global personal hygiene market during May 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global personal hygiene market throughout the month. Additionally, the report provides an overview of al …
- 工業用テープの世界市場2016-2020About Industrial Tapes Industrial tapes stick to substances when pressure is applied, without any need for solvent, heat, or any other activator. Many variants of these tapes are available in the market, such as single-sided, double-sided, adhesive transfer or transfer adhesive, single-coated, double-coated, carton sealing, masking, electrical and electronics, and others. Adhesive tapes are used f …
- RFID in AgricultureRFID in Agriculture provides the reader with an understanding of RFID and its current and future use in agriculture systems, processes, and procedures. This report reveals the path traversed by RFID, evaluating some of the most important implementations of RFID within the agriculture and food industries. Throughout this report there are real life facts with figures so that the reader can judge the …
- 家庭用ベビー動き監視モニターの世界市場2016-2020About the Home-Use Baby Movement Monitor Market Baby movement monitors are gaining traction across the world due to the introduction of new smart formats with additional functionalities. New parents adopt baby movement monitors to ensure the safety of their child. Tech-savvy consumers, especially parents who use baby care apps, are also the key end-users of baby movement monitors. These devices tr …
- がん用バイオマーカーの世界市場予測（～2022年）：タンパク質バイオマーカー、遺伝子バイオマーカーThe global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of 12.2% from 2017 to 2022. Over the years, the cancer biomarkers market has evolved significantly owing to the rising prevalence of cancer, advancements in omics technologies, increasing healthcare expenditure, growth in R&D funding from government and private bodies, and …
- Diabetic Gastroparesis：グローバル臨床試験レビューH1, 2013Diabetic Gastroparesis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Diabetic Gastroparesis Global Clinical Trials Review, H1, 2013" provides data on the Diabetic Gastroparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Gastroparesis. It includes an overview of the trial numbers and …
- スマートサーモスタットの世界市場：種類別（WiFi、赤外線、Bluetooth、その他）、用途別（分割AC、ウィンドウAC、ポータブルAC、その他）、最終用途別（住宅、商業、工業、その他）The global smart thermostat market is expected to generate revenue worth $1.36 billion in 2019, and is projected to reach $8.78 billion by 2026, to register a CAGR of 26.0% during the forecast period. Smart thermostat is the new kit of advanced technology that connects heating systems to the internet. This provides users the access to switch heating systems through the internet connected devices. …
- 石油・ガス産業向けモビリティ・アプリケーションの世界市場With the advent of technological innovations, coupled with the ever increasing need of exploring and producing oil and gas more competently, continues to transform the way the oil and gas industry functions. The most critical challenge is to locate the best ways to make resources such as data, technology, people, and processes more cost-efficient thereby ensuring optimum utilization of resources. …
- Mucopolysaccharidosis IV (MPS IV) (モルキオ症候群)：グローバル臨床試験動向（2014年上半期）Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome) Global Clinical Trials Review, H1, 2014" provides data on the Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome) clinical trial scenario. This report provides elemental information and data relating to the c …
